Pediatric Preclinical Testing Consortium evaluation of 4′-thio-2′-deoxycytidine (TdCyd) and 5-aza-4′-thio-2′-deoxycytidine (Aza-TdCyd)

被引：2
|
作者：
Teicher, Beverly A. [1 ]
Lock, Richard B. [2 ]
Collins, Jerry M. [1 ]
Gorlick, Richard [3 ]
Kolb, E. Anders [4 ]
Houghton, Peter J. [5 ]
Kurmasheva, Raushan T. [5 ]
Li, Xiao-Nan [6 ]
Erickson, Stephen W. [7 ]
Guo, Yuelong [7 ]
Evans, Kathryn [2 ]
Qi, Lin [6 ]
Smith, Malcolm A. [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] UNSW Sydney, Childrens Canc Inst, Lowy Canc Res Ctr, Sydney, NSW, Australia
[3] MD Anderson, Houston, TX USA
[4] Nemours Ctr Canc & Blood Disorders, Wilmington, DE USA
[5] Greehey Childrens Canc Res Inst, San Antonio, TX USA
[6] Baylor Coll Med, Houston, TX 77030 USA
[7] RTI Int, Res Triangle Pk, NC USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-LB-B12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-B12
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4′-thio-2′-deoxycytidine and 5-aza-4′-thio-2′-deoxycytidine
    Thottassery, Jaideep V.
    Sambandam, Vijaya
    Allan, Paula W.
    Maddry, Joseph A.
    Maxuitenko, Yulia Y.
    Tiwari, Kamal
    Hollingshead, Melinda
    Parker, William B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) : 291 - 302
  • [2] Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4′-thio-2′-deoxycytidine and 5-aza-4′-thio-2′-deoxycytidine
    Jaideep V. Thottassery
    Vijaya Sambandam
    Paula W. Allan
    Joseph A. Maddry
    Yulia Y. Maxuitenko
    Kamal Tiwari
    Melinda Hollingshead
    William B. Parker
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 291 - 302
  • [3] First-in-human trial of 4′-thio-2′-deoxycytidine (TdCyd) in patients with advanced solid tumors
    Coyne, G. O'Sullivan
    Chen, A.
    Kummar, S.
    Collins, J. M.
    Meehan, R. S.
    Suto, M.
    Rubinstein, L.
    Kinders, R.
    Moore, N.
    Parchment, R.
    Horneffer, Y.
    Juwara, L.
    Difilippantonio, M.
    Piekarz, R.
    Doroshow, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Phase I trial of 5-aza-4′-thio-2′-deoxycytidine (Aza-TdC) in patients with advanced solid tumors.
    Nguyen, James
    Coyne, Geraldine Helen O'Sullivan
    Takebe, Naoko
    Naqash, Abdul Rafeh
    Mukherjee, Jessica
    Bruns, Ashley
    Piekarz, Richard
    Collins, Jerry M.
    Anderson, Larry
    Miller, Brandon
    Parchment, Ralph E.
    Rubinstein, Larry V.
    Kummar, Shivaani
    Sharon, Elad
    Streicher, Howard
    Chen, Alice P.
    Doroshow, James H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] 5-Aza-4'-thio-2'-deoxycytidine induces C to G transversions in a specific trinucleotide context and leads to acute lymphoid leukemia
    Bertoli, Ryan Matthew
    Chung, Yang Jo
    Difilippantonio, Michael
    Wokasch, Anthony
    Marasco, Madison R.
    Klimaszewski, Haley
    Garber, Susannah
    Zhu, Yuelin Jack
    Walker, Robert L.
    Cao, Dengchao
    Doroshow, James
    Meltzer, Paul
    Aplan, Peter D.
    CANCER RESEARCH, 2024, 84 (06)
  • [6] The DNA Methyltransferase Inhibitor 5-Aza-4′-thio-2′-Deoxycytidine Induces C>G Transversions and Acute Lymphoid Leukemia Development
    Bertoli, Ryan M.
    Chung, Yang Jo
    Difilippantonio, Michael J.
    Wokasch, Anthony
    Marasco, Madison R. B.
    Klimaszewski, Haley
    Gammell, Susannah
    Zhu, Yuelin J.
    Walker, Robert L.
    Cao, Dengchao
    Khanna, Ajay
    Walter, Matthew J.
    Doroshow, James H.
    Meltzer, Paul S.
    Aplan, Peter D.
    CANCER RESEARCH, 2024, 84 (15) : 2518 - 2532
  • [7] Trial in progress abstract phase I trial of 5-aza-4′-thio-2′-deoxycytidine (Aza-TdC) in patients with advanced solid tumors.
    Monge, M. Cecilia B.
    Coyne, Geraldine Helen O'Sullivan
    Piekarz, Richard
    Takebe, Naoko
    Bruns, Ashley
    Mittra, Arjun
    Khan, Sabrina Sharmin
    Collins, Jerry M.
    Anderson, Larry
    Juwara, Lamin
    Miller, Brandon
    Kinders, Robert J.
    Rubinstein, Larry
    Chen, Alice P.
    Doroshow, James H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Comparison of thio-deoxy-cytidine (TdCyd) and aza-thio-deoxy-cytidine (Aza-TdCyd) in solid and liquid tumor cell lines and PPTC pediatric xenografts
    Teicher, Beverly A.
    Lock, Richard B.
    Evans, Kathryn
    Houghton, Peter J.
    Kurmasheva, Raushan T.
    Gorlicki, Richard
    Erickson, Steve
    Wishka, Donn
    Morris, Joel
    Difilippantonio, Michael
    Collins, Jerry E.
    Smith, Malcolm A.
    Doroshow, James H.
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Pre-clinical development of 4′-thio-2′-deoxycytidine (TdCyd) as a DNA-demethylating agent for use in treating solid tissue tumors
    Kinders, Robert J.
    Hollingshead, Melinda
    Thottassery, Jaideep
    Parker, William B.
    Pfister, Thomas D.
    Anderson, Lawrence W.
    Tomaszewski, Joseph E.
    Collins, Jerry M.
    Doroshow, James H.
    CANCER RESEARCH, 2014, 74 (19)
  • [10] The development of β-selective glycosylation reactions with benzyl substituted 2-deoxy-1,4-dithio-D-erythro-pentofuranosides: enabling practical multi-gram syntheses of 4'-Thio-2'-deoxycytidine (T-dCyd) and 5-aza-4'-thio-2'-deoxycytidine (aza-T-dCyd) to support clinical development
    Wishka, Donn G.
    Lopez, Omar D.
    Rudchenko, Vladimir F.
    Huang, Guangfei
    Bahde, Robert
    Kumar, Vineet
    Denysenko, Sergiy M.
    Zhang, Lianhao
    Zhang, Mianji
    Teicher, Beverly A.
    Morris, Joel
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2021, 40 (01): : 68 - 95
12345